These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2455835)

  • 1. Demonstration of the potent antihypertensive activity of phenyl-2-aminoethyl sulfides.
    Herman HH; Pollock SH; Fowler LC; May SW
    J Cardiovasc Pharmacol; 1988 May; 11(5):501-10. PubMed ID: 2455835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
    Pollock SH; Reichbaum MI; Colbert JC; Husain PA; Holbrook JM; Ogonowski AA; Khlief JS; May SW
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1113-7. PubMed ID: 8509996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phenyl-2-aminoethyl sulfide, a novel dopamine-beta-hydroxylase substrate, on the cardiovascular system of the anesthetized dog.
    Herman HH; Pollock SH; Padgette SR; Lange JR; Han JH; May SW
    J Cardiovasc Pharmacol; 1983; 5(5):725-30. PubMed ID: 6195457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the antihypertensive activity of phenyl-2-aminoethyl selenide.
    Pollock SH; Herman HH; Fowler LC; Edwards AS; Evans CO; May SW
    J Pharmacol Exp Ther; 1988 Jul; 246(1):227-34. PubMed ID: 3392654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine beta-hydroxylase.
    Padgette SR; Herman HH; Han JH; Pollock SH; May SW
    J Med Chem; 1984 Oct; 27(10):1354-7. PubMed ID: 6481771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the adrenergic uptake specificity of phenyl-2-aminoethyl sulfides.
    Pollock SH; Herman HH; Dillard ML; May SW
    Arch Int Pharmacodyn Ther; 1988; 296():76-86. PubMed ID: 3240025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antihypertensives targeted at dopamine beta-monooxygenase: turnover-dependent cofactor depletion by phenyl aminoethyl selenide.
    May SW; Wimalasena K; Herman HH; Fowler LC; Ciccarello MC; Pollock SH
    J Med Chem; 1988 Jun; 31(6):1066-8. PubMed ID: 3373481
    [No Abstract]   [Full Text] [Related]  

  • 8. The enantiomeric specificity of the antihypertensive activity of 1-(phenylthio)-2-aminopropane, a synthetic substrate analogue for dopamine beta-monooxygenase.
    Herman HH; Husain PA; Colbert JE; Schweri MM; Pollock SH; Fowler LC; May SW
    J Med Chem; 1991 Mar; 34(3):1082-5. PubMed ID: 2002450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
    Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats.
    Perusquía M; Herrera N; Ferrer M; Stallone JN
    J Steroid Biochem Mol Biol; 2017 Mar; 167():106-114. PubMed ID: 27888135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cardiovascular parameters of a selenium-based antihypertensive using pulsed Doppler ultrasound.
    Overcast JD; Ensley AE; Buccafusco CJ; Cundy C; Broadnax RA; He S; Yoganathan AP; Pollock SH; Hartley CJ; May SW
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):337-46. PubMed ID: 11486238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
    Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Abdallah HH; Johns EJ
    Eur J Pharmacol; 2009 Jun; 612(1-3):69-74. PubMed ID: 19356722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Sherman SS; Erickson R; DeWolf WE; Berkowitz BA
    J Pharmacol Exp Ther; 1987 May; 241(2):554-9. PubMed ID: 3572812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.